(Q39976481)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18516499%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Development of water soluble derivatives of cis-3, 4', 5-trimethoxy-3'-aminostilbene for optimization and use in cancer therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18516499%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

David E Durrant

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18516499%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Joanna Richards

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18516499%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Ashutosh Tripathi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18516499%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Paolo Marchetti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18516499%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Giuseppina Grisolia

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18516499%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Daniele Simoni

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18516499%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Ray M Lee

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18516499%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

31 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18516499%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18516499%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18516499%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18516499%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

41-52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18516499%20AND%20SRC:MED&resulttype=core&format=json

Taking down tumors: vascular disrupting agents entering clinical trials

8 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10637-008-9139-Y

Broad phase II and pharmacokinetic study of methoxy-morpholino doxorubicin (FCE 23762-MMRDX) in non-small-cell lung cancer, renal cancer and other solid tumour patients

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10637-008-9139-Y

ATM is activated by default in mitosis, localizes at centrosomes and monitors mitotic spindle integrity.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10637-008-9139-Y

A phase II study of KRN8602(MX2), a novel morpholino anthracycline derivative, in patients with recurrent malignant glioma

21 January 2018

1 reference

12 December 2020

Bub1 and aurora B cooperate to maintain BubR1-mediated inhibition of APC/CCdc20.

1 reference

12 December 2020

Design and synthesis of water-soluble glucuronide derivatives of camptothecin for cancer prodrug monotherapy and antibody-directed enzyme prodrug therapy (ADEPT)

1 reference

12 December 2020

Angiogenesis research: guidelines for translation to clinical application.

1 reference

12 December 2020

Potentiality of DNA-dependent protein kinase to phosphorylate Ser46 of human p53.

1 reference

12 December 2020

Recent progress in the management of advanced renal cell carcinoma

1 reference

12 December 2020

Combretastatin A-4 phosphate as a tumor vascular-targeting agent: early effects in tumors and normal tissues.

1 reference

12 December 2020

Angiogenesis: an organizing principle for drug discovery?

1 reference

12 December 2020

Synthesis and biological properties of bioreductively targeted nitrothienyl prodrugs of combretastatin A-4

1 reference

12 December 2020

Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents

1 reference

12 December 2020

Vascular-targeting therapies for treatment of malignant disease.

1 reference

12 December 2020

Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores

1 reference

12 December 2020

MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis.

1 reference

12 December 2020

Targeting vascular endothelial growth factor and angiogenesis for the treatment of colorectal cancer

1 reference

12 December 2020

Assessment of pharmacodynamic vascular response in a phase I trial of combretastatin A4 phosphate

1 reference

12 December 2020

Protein kinase C delta regulates Ser46 phosphorylation of p53 tumor suppressor in the apoptotic response to DNA damage

1 reference

12 December 2020

Ser58 of mouse p53 is the homologue of human Ser46 and is phosphorylated by HIPK2 in apoptosis

1 reference

12 December 2020

Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors.

1 reference

12 December 2020

Synthesis of self-immolative glucuronide-based prodrugs of a phenol mustard

1 reference

12 December 2020

Combretastatin A4 prodrug study of effect on the growth and the microvasculature of colorectal liver metastases in a murine model

1 reference

12 December 2020

Disrupting tumour blood vessels

1 reference

12 December 2020

Phase I clinical evaluation of weekly administration of the novel vascular-targeting agent, ZD6126, in patients with solid tumors

1 reference

12 December 2020

Mechanism of cell death induced by cis-3, 4', 5-trimethoxy-3'-aminostilbene in ovarian cancer

1 reference

12 December 2020

Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies

1 reference

12 December 2020

The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastrophe

1 reference

12 December 2020

cis-3, 4', 5-Trimethoxy-3'-aminostilbene disrupts tumor vascular perfusion without damaging normal organ perfusion

1 reference

12 December 2020

Vascular targeting agents as cancer therapeutics

1 reference

12 December 2020

A prospective randomized trial of KRN8602 and cytosine arabinoside vs. daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. The KRN8602 Leukemia Study Group.

1 reference

12 December 2020

Stilbene derivatives that are colchicine-site microtubule inhibitors have antileukemic activity and minimal systemic toxicity

1 reference

12 December 2020

Centrosomal localization of DNA damage checkpoint proteins

1 reference

12 December 2020

Phase I clinical trial of weekly combretastatin A4 phosphate: clinical and pharmacokinetic results

1 reference

12 December 2020

Tumour vascular targeting

1 reference

12 December 2020

Characterization of covalent DNA binding of morpholino and cyanomorpholino derivatives of doxorubicin

1 reference

12 December 2020

Phase II trial of pre-irradiation KRN8602 (MX2) in malignant glioma patients.

1 reference

12 December 2020

Vascular endothelial growth factor-targeted therapy in renal cell carcinoma: current status and future directions

1 reference

12 December 2020

Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow

1 reference

12 December 2020

A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer.

1 reference

12 December 2020

10.1007/S10637-008-9139-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18516499%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference